Facebook Pixel The bar for successful obesity drugs has been rising sharply | Mint New Delhi - newspaper - Lees dit verhaal op Magzter.com

Poging GOUD - Vrij

The bar for successful obesity drugs has been rising sharply

Mint New Delhi

|

January 02, 2025

Nothing else explains why Novo's stock fell after a drug test result

- LISA JARVIS

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company's stock price to fall by as much as 29%. Yes, fall. For anyone not following the heated race for obesity drug dominance, it may look like we're living upside-down. After all, if this data were unveiled three years ago, the market reaction would have been wildly different. The stock might have gone up and headlines would have heralded an advance in the fight against obesity. But we're in a new era of obesity medicine. The bar for success, once modest, has soared—especially so for CagriSema. Let me explain.

Though Novo will make mind-blowing money from its existing obesity drugs in the coming years (its GLP-1 drugs are likely to become pharma's most lucrative franchise next year), CagriSema was seen as essential for continued growth in 2030 and beyond. And the study suggests it may not be the contender investors had hoped for.

MEER VERHALEN VAN Mint New Delhi

Mint New Delhi

Mint New Delhi

Refiners raise LPG output by 10%, tie up supply from US

Indian refiners have ramped up daily domestic production of liquefied petroleum gas (LPG) by around 10% in the past few days in the face of a supply squeeze from the US-Iran war, two people aware of the development said.

time to read

3 mins

March 11, 2026

Mint New Delhi

OIL ON THE BOIL: IRAN WAR VS PAST SHOCKS

When the US and Israel began bombing Iran on 28 February, crude oil prices rose but not significantly in at least a couple of days.

time to read

4 mins

March 11, 2026

Mint New Delhi

Equities in favour

February data from the Association of Mutual Funds in India signals a rise in equity appetite.

time to read

1 min

March 11, 2026

Mint New Delhi

Mint New Delhi

Why eateries are raising the alarm over LPG supply

The restaurant industry has raised concerns after a government order prioritizing cooking gas for household use triggered confusion over the availability of commercial cylinders used by eateries.

time to read

2 mins

March 11, 2026

Mint New Delhi

IDFC First settles ₹645-cr fraud case

IDFC First Bank said it has settled fraud claims at its Chandigarh branch of ₹645 crore and found no further discrepancies.

time to read

1 min

March 11, 2026

Mint New Delhi

Mint New Delhi

Cabinet clears final IBC amendments

The Union cabinet on Tuesday approved the final amendments to the Insolvency and Bankruptcy Code (IBC), for which legislation will be moved in the Parliament in the ongoing session, two persons familiar with the development said.

time to read

2 mins

March 11, 2026

Mint New Delhi

Has Street already priced in AU's universal banking leap?

AU's universal banking transition should help sustain growth and reduce costs.

time to read

1 mins

March 11, 2026

Mint New Delhi

Edible oil buyers seek secure supply

If successful, model can improve warnings, disaster preparedness, agricultural planning

time to read

1 min

March 11, 2026

Mint New Delhi

Mint New Delhi

Royal Orchid bets on both asset-light, ownership models

SE-listed Royal Orchid Hotels is pursuing measured expansion as India’s hospitality boom gathers pace, blending asset-light growth with selective ownership bets.

time to read

1 mins

March 11, 2026

Mint New Delhi

Mint New Delhi

Trump says war to end 'very soon,' floats ending sanctions

US president insists operation was ahead of schedule, looks to shore up investors concerned about energy prices

time to read

2 mins

March 11, 2026

Listen

Translate

Share

-
+

Change font size